SCHEMBL27280649

SCHEMBL27280649

C=CC(=O)N1CCN(C(C)I)C(C(F)(F)F)C1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TEAD1 P28347 11/20 0.40
BTK Q06187 1/20 0.32
EGFR P00533 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20326324 0.88 TEAD1 (0.39) TEAD1BTK
SCHEMBL21741246 0.77 TEAD1 (0.36) TEAD1BTKEGFR
SCHEMBL21565892 0.74 TEAD1 (0.36) TEAD1BTK
SCHEMBL23735830 0.74 TEAD1 (0.39) TEAD1BTK
SCHEMBL17897298 0.71 PIK3C3 (0.36)
SCHEMBL20314874 0.71 TEAD1 (0.36) TEAD1BTK
SCHEMBL23308477 0.70 TEAD1 (0.37) TEAD1
SCHEMBL23308415 0.69 JAK3 (0.38) TEAD1BTK
SCHEMBL20314879 0.69 JAK3 (0.38) TEAD1BTK
SCHEMBL23569900 0.69 JAK3 (0.38) TEAD1BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3790886-B1 KRAS G12C INHIBITORS FOR THE TREATMENT OF CANCER AMGEN INC (US) 2024-06-26 EP disclosed